The global immunoassay market is expected to grow with a CAGR of 5%-7% by 2025


   January 13, 2021
According to a new market report published by Lucintel, the future of the immunoassay market looks promising with opportunities in hospitals, blood banks, clinical laboratories, pharmaceutical and biotech companies, and academic research centers. The global immunoassay market is expected to grow with a CAGR of 5%-7% from 2020 to 2025. The major drivers for this market are rising prevalence of chronic and infectious diseases, technological advancements in POC testing products, and growing patient awareness of POC testing.

Immunoassay is a procedure for detecting or measuring specific proteins or other substances through their properties as antigens or antibodies. In this market, reagents & kits, analyzers, and software are the major by product and service segments. Lucintel forecasts that reagents & kits will remain the largest product and service segment over the forecast period due to the requirement of repeat purchases of kits and reagents, increasing number of immunoassay tests, and rising incidence of chronic and infectious diseases.

Within this market, hospitals will remain the largest end user segment over the forecast period due to increase in prevalence of chronic diseases, such as cancer, infectious diseases, and autoimmune diseases.

North America will remain the largest region over the forecast period due to increasing incidence of chronic diseases and improved healthcare infrastructure in the region.

Roche, Abbott Laboratories, Siemens, Danaher Corporation, Sysmex Corporation, BioMérieux, Ortho Clinical Diagnostics, DiaSorin, QIAGEN, and Thermo Fisher Scientific are among the major suppliers in the global immunoassay market.

Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global immunoassay market by product and service, technology, application, platform, specimen, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Immunoassay Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global immunoassay market by product and service, technology, application, platform, specimen, end user, and region as follows:

By Product and Service [Value ($ Million) shipment analysis for 2014 – 2025]:



  • Reagents & Kits


  • Analyzers


  • Software


By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:



  • ELISA


  • First-Generation


  • Second-Generation


  • Third-Generation


  • Fourth-Generation & Above


  • Rapid Tests


  • Western Blotting


  • ELISPOT


  • Immuno-PCR


  • Other Technologies


By Application [Value ($ Million) shipment analysis for 2014 – 2025]:



  • Infectious Diseases


  • Endocrinology


  • Oncology


  • Bone & Mineral Disorders


  • Cardiology


  • Hematology & Blood Screening


  • Autoimmune Disorders


  • Toxicology


  • Neonatal Screening


  • Other Applications


By Platform [Value ($ Million) shipment analysis for 2014 – 2025]:



  • Chemiluminescence Immunoassays (CLIAs)


  • Fluorescence Immunoassays (FIAs)


  • Colorimetric Immunoassays (CIs)


  • Radioimmunoassays (RIAs)


  • Other Platforms


By Specimen [Value ($ Million) shipment analysis for 2014 – 2025]:



  • Blood


  • Saliva


  • Urine


  • Other Specimens


By End User [Value ($ Million) shipment analysis for 2014 – 2025]:



  • Hospitals


  • Blood Banks


  • Clinical Laboratories


  • Pharmaceutical and Biotech Companies


  • Academic Research Centers


  • Others


By Region [Value ($ Million) shipment analysis for 2014 – 2025]:



  • North America




  • United States


  • Canada


  • Mexico




  • Europe




  • United Kingdom


  • Spain


  • Germany


  • France




  • Asia Pacific




  • China


  • India


  • Japan




  • The Rest of the World




  • Brazil


 

This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.

Lucintel Corporate Customers

Market Entry, M & A, Opportunity Screening,...

Private Equity Customers

Buy Side Services (target screening, due diligence, ..)

Customer Quotes

"With more than 20 years experience in the industry, this is the first time we have come across such an extensive market analysis for our industry." Ven Cote, CEO, ZCL

"The insights we gained from Lucintel work helped with our business plan…a wonderful professional job…" Mike Jackson, Stahlin

"The report from Lucintel is useful not only for business planners, but also for the technology officers wanting to create a roadmap …" Dr. Giulio Ranzo, Booz Allen

"The information is so comprehensive, it has allowed us to identify & focus our business development efforts. It saved months of leg-work." Bill Barz, L&L Products

"We bought Lucintel report because it is the best report about our industry…a complete and appropriate analysis." Cesare Andrenacci, Ferretti